Axcess News – Lifestyle
Author:
Mylan Inc.
Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results
March 6, 2026
FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia
March 5, 2026
←
Previous Page
1
2